Literature DB >> 28183075

Morbidity in Depressive Disorders.

Ross J Baldessarini1, Alberto Forte, Valerio Selle, Kang Sim, Leonardo Tondo, Juan Undurraga, Gustavo H Vázquez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28183075     DOI： 10.1159/000448661

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN： 0033-3190            Impact factor:   17.659


× No keyword cloud information.
  20 in total

1.  Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study.

Authors:  Laura E Dichtel; Maren Nyer; David Mischoulon; Maurizio Fava; Karen K Miller; Christina Dording; Lauren B Fisher; Cristina Cusin; Benjamin G Shapero; Paola Pedrelli; Allison S Kimball; Elizabeth M Rao
Journal:  J Clin Psychiatry       Date:  2020-06-09       Impact factor: 4.384

2.  Longer-term open-label study of adjunctive riluzole in treatment-resistant depression.

Authors:  Hitoshi Sakurai; Christina Dording; Albert Yeung; Simmie Foster; Felipe Jain; Trina Chang; Nhi-Ha Trinh; Richard Bernard; Sean Boyden; Syed Z Iqbal; Samuel T Wilkinson; Sanjay J Mathew; David Mischoulon; Maurizio Fava; Cristina Cusin
Journal:  J Affect Disord       Date:  2019-07-02       Impact factor: 4.839

3.  Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis.

Authors:  J E J Buckman; A Underwood; K Clarke; R Saunders; S D Hollon; P Fearon; S Pilling
Journal:  Clin Psychol Rev       Date:  2018-07-29

4.  Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).

Authors:  Maurizio Fava; Marlene P Freeman; Martina Flynn; Bettina B Hoeppner; Richard Shelton; Dan V Iosifescu; James W Murrough; David Mischoulon; Cristina Cusin; Mark Rapaport; Boadie W Dunlop; Madhukar H Trivedi; Manish Jha; Gerard Sanacora; Gretchen Hermes; George I Papakostas
Journal:  Brain Stimul       Date:  2017-09-23       Impact factor: 8.955

5.  Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder.

Authors:  Hitoshi Sakurai; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price; George I Papakostas; Christina M Dording; Albert S Yeung; Cristina Cusin; Elizabeth Ludington; Richard Bernard-Negron; Maurizio Fava; David Mischoulon
Journal:  J Affect Disord       Date:  2019-10-31       Impact factor: 4.839

6.  Hormone therapy and the decreased risk of dementia in women with depression: a population-based cohort study.

Authors:  Hyewon Kim; Juhwan Yoo; Kyungdo Han; Dong-Yun Lee; Maurizio Fava; David Mischoulon; Hong Jin Jeon
Journal:  Alzheimers Res Ther       Date:  2022-06-16       Impact factor: 8.823

7.  Impaired Oxygenation of the Prefrontal Cortex During Verbal Fluency Task in Young Adults With Major Depressive Disorder and Suicidality: A Functional Near-Infrared Spectroscopy Study.

Authors:  Hyewon Kim; JongKwan Choi; Bumseok Jeong; Maurizio Fava; David Mischoulon; Mi Jin Park; Hyun Soo Kim; Hong Jin Jeon
Journal:  Front Psychiatry       Date:  2022-06-23       Impact factor: 5.435

8.  Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.

Authors:  Christian A Webb; Madhukar H Trivedi; Zachary D Cohen; Daniel G Dillon; Jay C Fournier; Franziska Goer; Maurizio Fava; Patrick J McGrath; Myrna Weissman; Ramin Parsey; Phil Adams; Joseph M Trombello; Crystal Cooper; Patricia Deldin; Maria A Oquendo; Melvin G McInnis; Quentin Huys; Gerard Bruder; Benji T Kurian; Manish Jha; Robert J DeRubeis; Diego A Pizzagalli
Journal:  Psychol Med       Date:  2018-07-02       Impact factor: 7.723

9.  A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder.

Authors:  G I Papakostas; K Johe; H Hand; A Drouillard; P Russo; G Kay; R Kashambwa; B Hoeppner; M Flynn; A Yeung; M A Martinson; M Fava
Journal:  Mol Psychiatry       Date:  2019-01-09       Impact factor: 15.992

10.  5-HTTLPR and MTHFR 677C>T polymorphisms and response to yoga-based lifestyle intervention in major depressive disorder: A randomized active-controlled trial.

Authors:  Madhuri R Tolahunase; Rajesh Sagar; Rima Dada
Journal:  Indian J Psychiatry       Date:  2018 Oct-Dec       Impact factor: 1.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.